Biomarkers of exposure: Mycotoxins - Aflatoxin, deoxynivalenol and fumonisins

Issues in Toxicology

Volumn 2, Issue , 2012, Pages 50-86

  Turner, Paul C ^a,b   Van Der Westhuizen, Liana ^b   Da Costa, Andre Nogueira ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898746277     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: None     Document Type: Article

References (154)

1. Council for Agricultural Science and Technology (CAST), Potential economic costs of mycotoxins in the United States, in Mycotoxins: Risks in Plant, Animal and Human Systems, Task force report No. 139, Ames, IA, USA, 2003, pp. 136-142.
2. J. D. Miller, Fungi and mycotoxins in grain: implications for stored product research, J. Stored Prod. Res., 1995, 31, 1-16.
3. P. M. Scott, Biomarkers of human exposure to ochratoxin A, Food Add. Contam., 2005, 22 Suppl 1, 99-107.
4. J. Gilbert, P. Brereton and S. MacDonald, Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples, Food Add. Contam., 2001, 18(12), 1088-1093.
5. IARC, Monograph 56, Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, International Agency for Research on Cancer, Lyon, France, 1993.
6. A. A. Stark, Threat assessment of mycotoxins as weapons: molecular mechanisms of acute toxicity, J. Food Prot., 2005, 68(6), 1285-1293.
7. C. P Wild and P. C. Turner, The toxicology of aflatoxins as a basis for public health decisions, Mutagenesis, 17(6), 471-481.
8. N. Polychronaki, C. P. Wild, H. Mykkänen, H. Amra, M. Abdel-Wahhab, A. Sylla, M. Diallo, H. El-Nezami and P. C. Turner, Urinary biomarkers of aflatoxin exposure in young children from Egypt and Guinea, Food Chem. Toxicol., 2008, 46, 519-526.
9. 1 excretion in breast milk of selected Egyptian mothers, Food Chem. Toxicol., 2007, 45, 1210-1215.
10. 1 in breast milk of Egyptian mothers, Food Add. Contam., 2006, 23(7), 700-708.
11. P. C. Turner, C. Loffredo, S. El-Kafrawy, S. Ezzat, S. Eissa, S. Abdel-Latif, M. El-Daly, O. Nada and M. Abdel-Hamid, A survey of aflatoxin-albumin adducts in sera from Egypt, Food Add. Contam., 2008, 5, 583-587.
12. V. M. Scussel, P. Haas, Y. Gong, P. C. Turner and C. P. Wild, Study of aflatoxin exposure in a Brazilian population using an aflatoxin-albumin biomarker, in Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, ed. H. Njapau, S. Trujillo, H. P van Egmond and D. L. Park, Wageningen Academic Press, 2006, pp. 197-202.
13. C. P. Wild, Y. Z. Jiang, S. J. Allen, L. A. Jansen, A. J. Hall and R. Montesano, Aflatoxin-albumin adducts in human sera from different regions of the world, Carcinogenesis, 1990, 11(12), 2271-2274.
14. P. C. Turner, C. P. Wild and P. Scott. Aflatoxin-albumin biomarker survey of 200 Canadian sera samples (unpublished observation).
15. T. W. Kensler, B. D. Roebuck, G. N. Wogan and J. D. Groopman. Aflatoxin: A 50 year odyssey of mechanistic and translational toxicology, Toxicol. Sci., 2010. [Epub ahead of print] doi: 10.1093/toxsci/kfq283.
16. F. P. Guengerich, Y. F. Ueng, B. R. Kim, S. Langouet, B. Coles, R. S. Iyer, R. Thier, T. M. Harris, T. Shimada, H. Yamazaki, B. Ketterer and A. Guillouzo, Activation of toxic chemicals by cytochrome P450 enzymes: regio- and stereoselective oxidation of aflatoxin B1, Adv. Exp. Med. Biol., 1996, 387, 7-15.
17. E. P. Gallagher, K. L. Kunze, P. L. Stapleton and D. L. Eaton, The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4, Toxicol. Appl. Pharm., 1996, 141(2), 595-606.
18. M. Kitada and T. Kamataki, Cytochrome P450 in human fetal liver: significance and fetal-specific expression, Drug Metab. Rev., 1994, 26, 305-323.
19. D. Lacroix, M. Sonnier, A. Moncion, G. Cheron and T. Cresteil, Expression of CYP3A in the human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth, Eur. J. Biochem., 1997, 247(2), 625-34.
20. *1C allele, Pharmacogen. Genomics, 2005, 15(9), 625-31.
21. D. L. Eaton, H. S. Ramsdell and G. E. Neal, Biotransformation of the aflatoxins, in The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, ed. D. L. Eaton and J. D. Groopman, Academic Press, 1994, pp. 45-72.
22. V. M. Raney, T. M. Harris and M. P. Stone, DNA conformation mediates aflatoxin B1-DNA binding and the formation of guanine N7 adducts by aflatoxin B1 8, 9-exo-epoxide, Chem. Res. Toxicol., 1993, 6(1), 64-68.
23. J. D. Groopman, A. Hall, H. Whittle, G. Hudson, G. N. Wogan, R. Montesano and C. P. Wild, Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa, Cancer Epidemiol. Biomarkers Prev., 1992, 1, 221-228.
24. J. D. Groopman, J. Q. Zhu, P. R. Donahue, A. Pikul, L. S. Zhang, J. S. Chen and G. N. Wogan, Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China, Cancer Res., 1992, 52(1):45-52.
25. F. P. Guengerich, W. W. Johnson, T. Shimada, Y. F. Ueng, H. Yamazaki and S. Langouët, Activation and detoxication of aflatoxin B1, Mutat. Res., 1998, 402(1-2), 121-128.
26. S. Bodreddigari, L. K. Jones, P. A. Egner, J. D. Groopman, C. H. Sutter, B. D. Roebuck, F. P. Guengerich, T. W. Kensler and T. R. Sutter, Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3, Chem. Res. Toxicol., 2008, 21(5), 1134-1142.
27. F. P. Guengerich, H. Cai, M. McMahon, J. D. Hayes, T. R. Sutter, J. D. Groopman, Z. Deng and T. M. Harris, Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases, Chem. Res. Toxicol., 2001, 14(6), 727-737.
28. D. P. H. Hsieh and J. J. Wong, Biotransformation of the aflatoxins, in The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, ed. D. L. Eaton and J. D. Groopman, Academic Press, 1994, pp. 73-88.
29. G. Sabbioni, P. L. Skipper, G. Büchi and S. R. Tannenbaum, Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats, Carcinogenesis, 1987, 8(6), 819-824.
30. C. P. Wild, G. J. Hudson, G. Sabbioni, B. Chapot, A. J. Hall, G. N. Wogan, H. Whittle, R. Montesano and J. D. Groopman, Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa, Cancer Epidemiol. Biomarkers Prev., 1992, 1(3), 229-234.
31. L. S. Gan, P. L. Skipper, X. C. Peng, J. D. Groopman, J. S. Chen, G. N. Wogan and S. R. Tannenbaum, Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1, Carcinogenesis, 1988, 9(7), 1323-1235.
32. G. Sabbioni, S. Ambs, G. N. Wogan and J. D. Groopman, The aflatoxinlysine adduct quantified by high-performance liquid chromatography from human serum albumin samples, Carcinogenesis, 1990, 11(11), 2063-2066.
33. P. F. Scholl and J. D. Groopman, Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence, Cancer Epidemiol. Biomarkers Prev., 2008, 17(6), 1436-1439.
34. L. F. McCoy, P. F. Scholl, A. E. Sutcliffe, S. M. Kieszak, C. D. Powers, H. S. Rogers, Y. Y. Gong, J. D. Groopman, C. P. Wild and R. L. Schleicher, Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry, Cancer Epidemiol. Biomarkers Prev., 2008, 17(7), 1653-1657.
35. P. F. Scholl, P. C. Turner, A. E. Sutcliffe, A. Sylla, M. Diallo, M. D. Friesen, J. D. Groopman and C. P. Wild, Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA, Cancer Epidemiol. Biomarkers Prev., 2006, 15(4), 823-826.
36. N. M. Johnson, G. Qian, L. Xu, D. Tietze, A. Marroquin-Cardona, A. Robinson, M. Rodriguez, L. Kaufman, K. Cunningham, J. Wittmer, F. Guerra, K. C. Donnelly, J. H. Williams, J. S. Wang and T. D. Phillips, Aflatoxin and PAH exposure biomarkers in a U. S. population with a high incidence of hepatocellular carcinoma, Sci. Total Environ., 2010, 408(23), 6027-6031.
37. Y. Y. Gong, K. Cardwell, A. Hounsa, S. Egal, P. C. Turner, A. J. Hall and C. P. Wild, Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo, West Africa: Cross sectional study, Br. Med. J., 2002, 325, 20-21.
38. Y. Y. Gong, A. Hounsa, S. Egal, P. C. Turner, A. E. Sutcliffe, A. J. Hall, K. Cardwell and C. P. Wild, Post-weaning exposure to aflatoxin results in impaired child growth: A longitudinal study in Benin, West Africa, Environ. Health Persp., 2004 112, 1334-1338.
39. F. M. Shuaib, P. E. Jolly, J. E. Ehiri, Y. Jiang, W. O. Ellis, J. K. Stiles, N. J. Yatich, E. Funkhouser, S. D. Person, C. Wilson and J. H. Williams, Association between anemia and aflatoxin B1 biomarker levels among pregnant women in Kumasi, Ghana, Am. J. Trop. Med. Hyg., 2010, 83(5), 1077-1083.
40. P. C. Turner, A. Sylla, S. Y. Kuang, C. L. Marchant, M. S. Diallo, A. J. Hall, J. D. Groopman and C. P. Wild, Absence of TP53 codon 249 mutations in Guinean infants with high aflatoxin exposure, Cancer Epidemiol. Biomarkers Prev., 2005, 14(8), 2053-2055.
41. P. C. Turner, A. C. Collinson, Y. B. Cheung, Y. Y. Gong, A. J. Hall, A. M. Prentice and C. P. Wild, Aflatoxin exposure in utero causes growth faltering in Gambian infants, Int. J. Epidemiol., 2007, 36, 1119-1125.
42. A. C. Collinson, P. C. Turner, A. J. Hall, C. P. Wild and A. M. Prentice, Aflatoxin-albumin biomarkers in Gambian infants, unpublished observations.
43. P. C. Turner, S. E. Moore, A. J. Hall, A. M. Prentice and C. P. Wild, Modification of immune function through exposure to dietary aflatoxin in Gambian children, Environ. Health Persp., 111(2), 217-220.
44. P. C. Turner, M. Mendy, H. Whittle, M. Fortuin, A. J. Hall and C. P. Wild, Hepatitis B infection and aflatoxin biomarker levels in Gambian children, Trop. Med. Internat. Health, 5(12), 837-841.
45. S. J. Allen, C. P. Wild, J. G. Wheeler, E. M. Riley, R. Montesano, S. Bennett, H. C. Whittle and A. J. Hall, Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children, Trans. Roy. Soc. Trop. Med. Hyg., 1992, 86, 426-430.
46. H. Ahsan, L. Y. Wang, C. J. Chen, W. Y. Tsai and R. M. Santella, Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype, Environ. Health Persp., 2001, 109(8), 833-837.
47. J. D. Groopman, C. P. Wild, J. Hasler, C. Junshi, G. N. Wogan and T. W. Kensler, Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans, Environ. Health Persp., 1993, 99, 107-113.
48. J. Q. Zhu, L. S. Zhang, X. Hu, Y. Xiao, J. S. Chen, Y. C. Xu, J. Fremy and F. S. Chu, Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine, Cancer Res., 1987, 47(7), 1848-1852.
49. A. Zarba, C. P. Wild, A. J. Hall, R. Montesano, G. J. Hudson and J. D. Groopman, Aflatoxin M1 in human breast milk from The Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC, Carcinogenesis, 1992, 13(5), 891-894.
50. W. P. Blount, Turkey 'X' disease, J. Br. Turkey Fed., 1961, 9, 52-54.
51. C. M Lancaster, F. P. Jenkins and P. Philip, Toxicity associated with certain samples of groundnuts, Nature, 1961, 192, 1095-1096.
52. T. Asao, G. Buchi, M. M. Abdel-Kader, S. B. Chang, E. L. Wick and G. N. Wogan, Aflatoxins B and G. J. Am. Chem. Soc., 1963, 85, 1706-1707.
53. J. M. Cullen and P. M. Newberne, Acute hepatotoxicity of aflatoxins, In The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, ed. D. L. Eaton and J. D. Groopman, Academic Press, 1994, pp. 3-26.
54. G. Ramjee, P. Berjak, M. Adhikari and M. F. Dutton, Aflatoxins and kwashiorkor in Durban, South Africa, Ann. Trop. Paediat., 1992, 12(3), 241-247.
55. F. E. Jonsyn-Ellis, Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls, Mycopathologia, 2001, 152(1), 35-40.
56. Y. M. Abdulrazzaq, N. Osman, Z. M. Yousif and O. Trad, Morbidity in neonates of mothers who have ingested aflatoxins, Ann. Trop. Paediat., 2004, 24(2), 145-151.
57. Y. M. Abdulrazzaq, N. Osman and A. Ibrahim, Fetal exposure to aflatoxins in the United Arab Emirates, Ann. Trop. Paediat., 2002, 22(1), 3-9.
58. F. E. Jonsyn, S. M. Maxwell and R. G. Hendrickse, Human fetal exposure to ochratoxin and aflatoxins, Ann. Trop. Paediat., 1995, 15(1), 3-9.
59. S. M. Maxwell, J. B. Familusi, O. Sodeinde, M. C. Chan and R. G. Hendrickse, Detection of naphthols and aflatoxins in Nigerian cord blood, Ann. Trop. Paediat., 1994, 14(1), 3-5.
60. C. P. Wild, F. N. Rasheed, M. F. Jawla, A. J. Hall, L. A. Jansen and R. Montesano, In utero exposure to aflatoxin in West Africa, Lancet, 1991, 337, 1602.
61. L. L. Hsieh and T. T. Hsieh, Detection of aflatoxin B1-DNA adducts in human placenta and cord blood, Cancer Res., 1993, 53(6), 1278-1280.
62. Y. Dersjant-Li, M. W. A. Verstegen and W. J. J. Gerrits, The impact of low concentrations of aflatoxin, deoxynivalenol or fumonisin in diets on growing pigs and poultry, Nutr. Res. Rev., 2003, 16, 223-239.
63. R. G. Hendrickse, Kwashiorkor and aflatoxins, J. Pediat. Gastroenterol. Nutr., 1988, 7(5), 633-636.
64. A. N. Tchana, P. F. Moundipa and F. M. Tchouanguep, Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon, Int. J. Environ. Res. Public Health, 2010, 7(1), 178-188.
65. S. Gratz, Q. K. Wu, H. El-Nezami, R. O. Juvonen, H. Mykkänen and P. C. Turner, Alteration of intestinal transport, metabolism and toxicity of aflatoxin B1 by Lactobacillus rhamnosus strain GG in vitro in Caco-2 cells, Appl. Environ. Microbiol., 2007, 73, 3958-3964.
66. Y. Y. Gong, P. C. Turner, A. J. Hall and C. P. Wild, Aflatoxin exposure and impaired child growth in West Africa: an unexplored international public health burden? in Mycotoxins Detection Methods, Management, Public Health and Agricultural Trade, ed. J. Leslie, R. Bandyopadhyay and A. Visconti, Cromwell Press, 2008, pp. 53-66.
67. J. H. Williams, T. D. Phillips, P. E. Jolly, J. K. Stiles, C. M. Jolly and D. Aggarwal, Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions, Am. J. Clin. Nutr. 80, 1106-1122.
68. B. A. Rotter, D. B. Prelusky and J. J. Pestka, Toxicology of deoxynivalenol (vomitoxin), J. Toxicol. Environ. Health, 1996, 48, 1-34.
69. Y. Luo, T. Yoshizawa and T. Katayama, Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high-risk and low-risk areas for human esophageal cancer in China, Appl. Environ. Microbiol., 1990, 56, 3723-3726.
70. R. V. Bhat, Y. Ramakrishna, S. R. Beedu and K. L. Munshi, Outbreak of trichothecene mycotoxicosis associated with consumption of mold-damaged wheat products in Kashmir Valley, India, Lancet, 1989, 1, 35-37.
71. Y. Ramakrishna, R. V. Bhat and V. Ravindranath, Production of deoxynivalenol by Fusarium isolates from samples of wheat associated with a human mycotoxicosis outbreak and from sorghum cultivars, Appl. Environ. Microbiol., 1989, 55, 2619-2620.
72. C. Cowger, J. Patton-Ozkurt, G. Brown-Guedira and L. Perugini, Postanthesis moisture increased Fusarium Head blight and deoxynivalenol levels in North Carolina winter wheat, Phytopathology, 2009, 99, 320-327.
73. SCOOP Report, Collection of Occurrence Data of Fusarium Toxins in Food and Assessment of Dietary Intake by the Population of Eu Member States, European Commission, Brussels, 2003.
74. F. Q. Li, Y. W. Li, X. Y. Luo and T. Yoshizawa, Fusarium toxins in wheat from an area in Henan Province, Pr China, with a previous human red mould intoxication episode, Food Addit. Contam., 2002, 19, 163-167.
75. F. Q. Li, X. Y. Luo and T. Yoshizawa, Mycotoxins (trichothecenes, zearalenone and fumonisins) in cereals associated with human redmold intoxications stored since 1989 and 1991 in China, Nat. Toxins, 1999, 7, 93-97.
76. X. Luo, Food poisoning caused by Fusarium toxins, Proceedings of Second Asian Conference in Food Safety, 1994, pp. 129-136.
77. J. J. Pestka and A. T. Smolinski, Deoxynivalenol: toxicology and potential effects on humans, J. Toxicol. Env. Health-Pt β-Crit. Rev., 2005, 8, 39-69.
78. Centres for Disease Control (CDC), Outbreaks of gastrointestinal illness of unknown etiology associated with eating burritos - United States, October 1997-October 1998. CDC MMWR, 1999, 48(10), 210-213, available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00056731.htm (accessed Feb. 01, 2011).
79. P. C. Turner, V. J. Burley, J. A. Rothwell, K. L. M. White, J. E. Cade and C. P. Wild, Deoxynivalenol: Rationale for development and application of a urinary biomarker, Food Add. Contam., 2008 25(7), 864-871.
80. P. C. Turner, Deoxynivalenol and nivalenol occurrence and exposure assessment, World Mycotoxin J., 3(4), 315-321.
81. D. B. Prelusky, R. G. Gerdes, K. L. Underhill, B. A. Rotter, P. Y. Jui and H. L. Trenholm, Effects of low-level dietary deoxynivalenol on haematological and clinical parameters of the pig, Nat. Toxins, 1994, 2, 97-104.
82. L. G. Young, L. McGirr, V. E. Valli, J. H. Lumsden and A. Lun, Vomitoxin in corn fed to young-pigs, J. Anim. Sci., 1983, 57, 655-664.
83. D. M. Hughes, M. J. Gahl, C. H. Graham and S. L. Grieb, Overt signs of toxicity to dogs and cats of dietary deoxynivalenol, J. Anim. Sci., 1999, 77, 693-700.
84. F. Iverson, C. Armstrong, E. Nera, J. Truelove, S. Fernie, P. Scott, R. Stapley, S. Hayward and S. Gunner, Chronic feeding study of deoxynivalenol in B6c3f1 male and female mice, Teratogen. Carcinogen. Mutagen., 1995, 15, 283-306.
85. G. S. Bondy and J. J. Pestka, Immunomodulation by fungal toxins, J. Toxicol. Env. Health-Pt β-Crit. Rev., 2000, 3, 109-143.
86. C. J. Amuzie, J. Shinozuka and J. J. Pestka, Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse, Toxicol. Sci., 2009, 111, 277-287.
87. J. J. Pestka and C. J. Amuzie, Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice, Food Chem. Toxicol., 2008, 46, 2826-2831.
88. P. Pinton, F. Accensi, E. Beauchamp, A. M. Cossalter, P. Callu, F. Grosjean and I. P. Oswald, Ingestion of deoxynivalenol (Don) contaminated feed alters the pig vaccinal immune responses, Toxicol. Lett., 2008, 177, 215-222.
89. H. R. Zhou, D. Yan and J. J. Pestka, Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (deoxynivalenol): differential toxin-induced hyporesponsiveness and recovery, Toxicol. Appl. Pharm., 1998, 151, 347-358.
90. S. Danicke, K. P. Brussow, H. Valenta, K. H. Ueberschar, U. Tiemann and M. Schollenberger, On the effects of graded levels of Fusarium toxin contaminated wheat in diets for gilts on feed intake, growth performance nd metabolism of deoxynivalenol and zearalenone, Mol. Nutr. Food Res., 2005, 49, 932-943.
91. P. He, L. G. Young and C. Forsberg, Microbial transformation of deoxynivalenol (vomitoxin), Appl. Environ. Microbiol., 1992, 58, 3857-3863.
92. K. Seeling, S. Danicke, H. Valenta, H. P. Van Egmond, R. C. Schothorst, A. A. Jekel, P. Lebzien, M. Schollenberger, E. Razzazi-Fazeli and G. Flachowsky, Effects of Fusarium toxin-contaminated wheat and feed intake level on the biotransformation and carry-over of deoxynivalenol in dairy cows, Food Addit. Contam., 2006, 23, 1008-1020.
93. T. Yoshizawa, L. M. Cote, S. P. Swanson and W. B. Buck, Confirmation of Dom-1, a deepoxidation metabolite of deoxynivalenol, in biologicalfluids of lactating cows, Agric. Biol. Chem., 1986, 50, 227-229.
94. J. C. Young, T. Zhou, H. Yu, H. H. Zhu and J. H. Gong, Degradation of trichothecene mycotoxins by chicken intestinal microbes, Food Chem. Toxicol., 2007, 45, 136-143.
95. G. S. Eriksen and H. Pettersson, Lack of de-epoxidation of Type B trichothecenes in incubates with human faeces, Food Addit. Contam., 2003, 20, 579-582.
96. F. A. Meky, P. C. Turner, A. E. Ashcroft, J. D. Miller, Y. L. Qiao, M. J. Roth and C. P. Wild, Development of a urinary biomarker of human exposure to deoxynivalenol, Food Chem. Toxicol., 2003, 41, 265-273.
97. P. C. Turner, V. J. Burley, J. A. Rothwell, K. L. M. White, J. E. Cade and C. P. Wild, Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults, J. Exp. Sci. Environ. Epidemiol., 2008, 18, 392-399.
98. P. C. Turner, J. A. Rothwell, K. L. M. White, Y. Gong, J. E. Cade and C. P. Wild, Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom, Environ. Health Persp., 2008, 116, 21-25.
99. P. C. Turner, K. L. M. White, V. Burley, R. Hopton, A. Rajendram, J. Fisher, J. E. Cade and C. P. Wild, A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults, Biomarkers, 2010 15(6), 553-562.
100. P. C. Turner, R. P. Hopton, Y. Lecluse, K. L. M. White, J. Fisher and P. Lebailly, Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France, J. Agric. Food Chem., 2010, 58, 5206-5212.
101. S. Piekkola, P. C. Turner, E. Savchenko, S. Ezzat, I. Kasem, T. Poussa, Y. Y. Y. Chung, H. Mykkänen, M. Abdel-Hamid M and H. El-Nezami, Characterization of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women, Submitted to Food Chem. Toxicol.
102. S. J. Hepworth, L. J. Hardie, L. K. Fraser, V. J. Burley, R. S. Mijal, C. P. Wild, R. Azad, P. A. McKinney and P. C. Turner, Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK, Food Add. Contam., in press.
103. P. C. Turner, R. Hopton, K. L. M. White, J. Fisher, J. E. Cade and C. P. Wild, Assessment of deoxynivalenol metabolite profiles in UK adults, Food Chem. Toxicol., 2011, 49, 132-135.
104. SCF, Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group Evaluation of T-2 toxin, HT-2 toxin, Nivalenol and Deoxynivalenol: 2002SCF/CS/CNTM/MYC/27, http://europa.eu.int/comm/food/fs/sc/scf/out123-en.pdf.
105. K. Hochstenbach, D. M. Van Leeuwen, H. Gmuender, S. B. Stolevik, U. C. Nygaard, M. Lovik, B. Granum, E. Namork, J. H. M. Van Delft and H. Van Loveren, Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells, Toxicol. Sci., 2010, 118, 19-30.
106. A. Nogueira Da Costa, R. S. Mijal, J. N. Keen, J. B. C. Findlay and C. P. Wild, Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol, Proteomics, 2010, in press.
107. A. Nogueira Da Costa, J. N. Keen, C. P. Wild and J. B. C. Findlay, An analysis of the phosphoproteome of immune cell lines exposed to the immunomodulatory mycotoxin deoxynivalenol, Biochim. Biophy. Acta-Prot. Proteom., 2010, Submitted.
108. A. M. Osman, J. L. A. Pennings, M. Blokland, A. Peijnenburg and H. Van Loveren, Protein expression profiling of mouse thymoma cells upon exposure to the trichothecene deoxynivalenol (Don): Implications for its mechanism of action, J. Immunotoxicol., 2010, 7, 147-156.
109. R. P. Hopton, E. Turner, V. J. Burley, P. C. Turner and J. Fisher, Urine metabolite analysis as a function of deoxynivalenol exposure: an NMRbasedmetabolomics investigation, Food Add. Contam. A, 2010, 27, 255-261.
110. W. F. O. Marasas, Discovery, occurrence of the fumonisins, a historical perspective, Environ. Health Persp., 2001, 109(S2), 239-243.
111. K. A. Voss, G. W. Smith and W. M. Haschek, Fumonisins: Toxicokinetics, mechanism of action and toxicity, Anim. Feed Sci. Technol., 2007, 137, 299-325.
112. W. C. Gelderblom, N. P. Kriek, W. F. Marasas and P. G. Thiel, Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats, Carcinogenesis, 1991, 12, 1247-1251.
113. W. C. A. Gelderblom, S. Riedel, H. M. Burger, S. Abel and W. F. O. Marasas, Carcinogenesis by the fumonisins, mechanisms, risk analyses, and implications, in Food Contaminants, Mycotoxins and Food Allergens, ed. D. P. Siantar, M. W. Trucksess, P. M. Scott, E. M. Herman, A. C. S. Symposium Series 1001, Washington, DC, 2008, pp. 80-95.
114. P. C. Howard, R. M. Eppley, M. E. Stack, A. Warbritton, K. A. Voss, R. J. Lorentzen, R. M. Kovach and T. J. Bucci, Fumonisin B1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice, Health Perspect., 2001, 109(S2), 277-282.
115. International Agency for Research on Cancer (IARC), Some traditional herbal medicines, some mycotoxins, naphthalene and styrene, in Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer Press, Lyon (France), 2002, pp. 301-366.
116. L. Xu, Q. Cai, L. Tang, S. Wang, X. Hu, J. Su, G. Sun, J. S. Wang, Evaluation of fumonisin biomarkers in a cross-sectional study with two high-risk populations in China, Food Add. Contam. A, 2010, 27, 1161-1619.
117. W. F. O. Marasas, R. T. Riley, K. A. Hendricks, V. L. Stevens, T. W. Sadler, J. Gelineau-van Waes, S. A. Missmer, J. Cabrera, O. Torres, W. C. Gelderblom, J. Allegood, C. Martinez, J. Maddox, J. D. Miller, L. Starr, M. C. Sullards, A. V. Roman, K. A. Voss, E. Wang and A. H. Merrill, Jr., Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo, a potential risk factor for human neural tube defects among populations consuming fumonisin contaminated maize, J. Nutr., 2004, 134, 711-716.
118. S. A. Missmer, L. Suarez, M. Felkner, E. Wang, A. H. Merrill Jr., K. J. Rothman and K. A. Hendricks, Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border, Environ. Health Persp., 2006, 114, 237-241.
119. J. B. Gelineau-van Waes, K. A. Voss, V. L. Stevens, M. C. Speer and R. T. Riley, Maternal fumonisin exposure as a risk factor for neural tube defects, Adv. Food Nutr. Res., 2009, 56, 145-181.
120. M. Bolger, R. D. Coker, M. Di Novi, D. Gaylor, W. C. Gelderblom, M. Olsen, N. Paster, R. T. Riley, G. S. Shephard and G. J. A. Speijers, Fumonisins, in Safety Evaluation of Certain Mycotoxins in Food, Food Additives Series No. 47, FAO Food and Nutrition Paper No. 47, Prepared for the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), World Health Organization (WHO), Geneva (Switzerland), 2001, pp. 103-279.
121. G. S. Shephard, N. L. Leggott, S. Stockenström, N. I. M. Somdyala and W. F. O. Marasas. Preparation of South African maize porridge: effect on fumonisin mycotoxin levels, S. Afr. J. Sci., 2002, 98, 393-396.
122. G. S. Shephard, W. F. O. Marasas, H. M. Burger, N. I. Somdyala, J. P. Rheeder, L. Van Der Westhuizen, P. Gatyeni and D. J. Van Schalkwyk, Exposure assessment for fumonisins in the former Transkei region of South Africa, Food Add. Contam., 2007, 24, 621-629.
123. H. M. Burger, M. J. Lombard, G. S. Shephard, J. R. Rheeder, L. Van Der Westhuizen and W. C. A. Gelderblom, Dietary fumonisin exposure in a rural population of South Africa, Food Chem. Toxicol., 2010, 48, 2103-2108.
124. W. T. Shier, The fumonisin paradox: A review of research on oral bioavailability of fumonisin B1, a mycotoxin produced by Fusarium moniliforme, J. Toxin Rev., 2000, 19, 161-187.
125. G. S. Shephard, P. G. Thiel and E. W. Sydenham, Initial studies on the toxicokinetics of fumonisin B1 in rats, Food Chem. Toxicol., 1992, 30, 277-279.
126. D. B. Prelusky, J. D. Miller and H. L. Trenholm, Disposition of 14Cderived residues in tissues of pigs fed radiolabelled fumonisin B1, Food Add. Contam., 1996, 13, 155-162.
127. 14C-fumonisin B1 in male Sprague-Dawley rats, Nat. Toxins, 1993, 1, 341-346.
128. 14C-labelled mycotoxin, fumonisin B1, in rats, Toxicon, 1992, 30, 768-770.
129. G. S. Shephard, P. G. Thiel, E. W. Sydenham, J. F. Alberts and M. E. Cawood. Distribution and excretion of a single dose of the mycotoxin fumonisin B1 in a non-human primate, Toxicon, 1994, 32, 735-741.
130. G. S. Shephard, P. G. Thiel, E. W. Sydenham and J. F. Alberts, Biliary excretion of the mycotoxin fumonisin B1 in rats, Food Chem. Toxicol., 1994, 32, 489-491.
131. 14C-labelled fumonisin B1 in vervet monkeys, Nat. Toxins, 1995, 3, 145-150.
132. G. S. Shephard, P. G. Thiel, E. W. Sydenham and P. W. Snijman, Toxicokinetics of the mycotoxin fumonisin B2 in rats, Food Chem. Toxicol., 1995, 33, 591-595.
133. G. S. Shephard and P. W. Snijman, Elimination and excretion of a single dose of the mycotoxin fumonisin B2 in a non-human primate, Food Chem. Toxicol., 1999, 37, 111-116.
134. P. Dilkin, G. Direito, M. M. Simas, C. A. Mallmann and B. Correa, Toxicokinetics and toxicological effects of single oral dose of fumonisin B1 containing Fusarium verticillioides culture material in weaned piglets, Chem. Biol. Interact., 2010, 185, 157-162.
135. A. H. Merrill Jr., M. C. Sullards, E. Wang, K. A. Voss and R. T. Riley, Sphingolipid metabolism, roles in signal transduction and disruption by fumonisins, Environ. Health Perspect., 2001, 109(Suppl 2), 283-289.
136. R. T. Riley, N. H. An, J. L. Showker, H. S. Yoo, W. P. Norred, W. J. Chamberlain, E. Wang, A. H. Merrill Jr., G. Motelin, V. R. Beasley and W. M. Haschek, Alteration of tissue and serum sphinganine to sphingosine ratio, an early biomarker for exposure to fumonisin-containing feeds in pigs, Toxicol. Appl. Pharm., 1993, 118, 105-112.
137. G. S. Shephard, L. Van Der Westhuizen and V. Sewram, Biomarkers of exposure to fumonisin mycotoxins: A review, Food Add. Contam., 2007, 24, 1196-1201.
138. Q. Cai, L. Tang and J. S. Wang, Validation of fumonisin biomarkers in F344 rats, Toxicol. Appl. Pharmacol., 2007, 225, 28-39.
139. M. Castegnaro, L. Garren, D. Galendo, W. C. Gelderblom, P. Chelule, M. F. Dutton and C. P. Wild, Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure, J. Chromatog. B Biomed. Sci. App., 1998, 720, 15-24.
140. L. Van Der Westhuizen, G. S. Shephard and D. J. Van Schalkwyk, The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys, Toxicon, 2001, 39, 969-972.
141. P. N. Nikiéma, L. Worrillow, A. S. Traore, C. P. Wild and C. P. Turner, Fumonisin exposure and the sphinganine/sphingosine ratio in urine, serum and buccal cells in adults from Burkina Faso, West Africa, World Mycotoxin J., 2008, 1, 483-491.
142. M. Qiu and X. Liu, Determination of sphinganine, sphingosine and sphinganine/sphingosine ratio in urine of humans exposed to dietary fumonisin B1, Food Add. Contam., 2001, 18, 263-269.
143. M. Solfrizzo, S. N. Chulze, C. Mallmann, A. Visconti, A. De Girolamo, F. Rojo and A. Torres, Comparison of urinary sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure, Food Add. Contam., 2004, 21, 1090-1095.
144. L. J. Silva, C. M. Lino and A. Pena, Sphinganine-sphingosine ratio in urine from two Portuguese populations as biomarker to fumonisins exposure, Toxicon, 2009, 54, 390-398.
145. L. Van Der Westhuizen, N. L. Brown, W. F. O. Marasas, S. Swanevelder and G. S. Shephard, Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa, Food Chem. Toxicol., 1999, 37, 1153-1158.
146. L. Van Der Westhuizen, G. S. Shephard, J. P. Rheeder, N. I. M. Somdyala and W. F. O. Marasas, Sphingoid base levels in humans consuming fumonisin contaminated maize from rural areas in the former Transkei, South Africa, A cross sectional study. Food Add. Contam. A, 2008, 11, 1385-1391.
147. L. Van Der Westhuizen, G. S. Shephard, J. P. Rheeder and H. M. Burger, Individual fumonisin exposure and sphingoid base levels in rural populations consuming maize in South Africa, Food Chem. Toxicol., 2010, 48, 1698-1703.
148. P. H. Shetty and R. V. Bhat, Sensitive method for the detection of fumonisin B1 in human urine, J. Chromatogr. B, 1998, 705, 171-173.
149. Y. Y. Gong, L. Torres-Sanchez, L. Lopez-Carrillo, J. H. Peng, A. E. Sutcliffe, K. L. White, H. U. Humpf, P. C. Turner and C. P. Wild, Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population, Cancer Epidemiol. Biomarkers Prev., 2008, 17, 688-694.
150. L. Van Der Westhuizen, Y. Y. Gong, G. S. Shephard, H. M. Burger, J. P. Rheeder, W. C. Gelderblom and C. P. Wild, Optimising sorting and washing of home-grown maize to reduce fumonisin contamination under laboratory-controlled conditions, Food Control, 2010, in press, DOI, 10.1016/j.foodcont.2010.09.009.
151. L. Van Der Westhuizen, G. S. Shephard, H. M. Burger, J. P. Rheeder, W. C. Gelderblom, C. P. Wild and Y. Y. Gong, Implementation of simple intervention methods to reduce fumonisin exposure in a subsistence maize farming community of South Africa, Food Add. Contam., 2010, 27, 1582-1588.
152. L. Van Der Westhuizen, G. S. Shephard, H. M. Burger, J. P. Rheeder, W. C. Gelderblom, C. P. Wild and Y. Y. Gong, Fumonisin B1 as a urinary biomarker of exposure in a maize intervention study among South African subsistence farmers, Cancer Epidemiol. Biomarkers Prev., 2011, in press.
153. V. Sewram, N. Mshicileli, G. S. Shephard, W. F. O. Marasas, Fumonisin mycotoxins in human hair, Biomarkers, 2003, 8, 110-118.
154. 1 in maize, Environ. Health Perspect., 2001, 109, 253-256.